Interest high but caveats remain for new weight loss drugs
- Nearly half of US adults express interest in using new weight loss drugs like Ozempic and Wegovy.
- Interest is higher among women and Hispanic adults compared to men and White or Black adults.
- Interest declines when people learn about required routine injections and potential to regain weight after stopping use.
- Interest also lower if drugs aren't covered by insurance or specifically FDA approved for weight loss.
- Over half believe these drugs should be covered by insurance, especially for overweight or obese individuals.
The Hill 
The Messenger 
POLITICO 
CNN 
